Clinical Trials Directory

Trials / Sponsors / VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc.

Industry · 11 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray f
Social Anxiety Disorder
Phase 22025-01-09
RecruitingFasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Social Anxiety Disorder (SAD)
Phase 32024-09-16
Active Not RecruitingFasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
Social Anxiety Disorder
Phase 32024-03-28
UnknownAV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia
Parkinson Disease, Dyskinesia, Medication-Induced, L-Dopa Causing Adverse Effects in Therapeutic Use
Phase 22022-08-01
UnknownAV-101 Alone and in Combination With Probenecid in Healthy Subjects
Drug Drug Interaction
Phase 12021-12-23
CompletedPH94B in the Treatment of Adjustment Disorder With Anxiety
Adjustment Disorder With Anxious Mood
Phase 22021-10-12
TerminatedOpen-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
Social Anxiety Disorder
Phase 32021-10-01
TerminatedPH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
Social Anxiety Disorder
Phase 32021-08-30
CompletedPH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
Social Anxiety Disorder
Phase 32021-05-24
CompletedAV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression
Major Depressive Disorder
Phase 22018-03-05
CompletedSafety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers
Neuropathic Pain
Phase 12011-12-01